<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Examination of 115 women for detection of <z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies (<z:chebi fb="79" ids="53407">PLA</z:chebi>), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies has demonstrated that in the absence of <z:chebi fb="79" ids="53407">PLA</z:chebi> <z:hpo ids='HP_0000001'>all</z:hpo> pregnancies terminated in the birth of full-term healthy children, while in their presence there were repeated abortions and (or) intrauterine <z:hpo ids='HP_0011420'>death</z:hpo> of a fetus </plain></SENT>
<SENT sid="1" pm="."><plain>Obstetrical pathology in women in the presence of <z:chebi fb="79" ids="53407">PLA</z:chebi> was attended by venous and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:hpo ids='HP_0005318'>cerebral vasculitis</z:hpo> and vascular affections, which is typical of the picture of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A new approach has been suggested to the treatment of such patients with reduction of the activity of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> antibodies owing to which pregnancy can be terminated in the birth of viable children </plain></SENT>
</text></document>